Pre-clinical development of broad-spectrum antiviral strategies against human respiratory viruses of pandemic concern
Pre-clinical development of broad-spectrum antiviral strategies against human respiratory viruses of pandemic concern
批准号:
462582
负责人:
Jean François
金额:
$68.88万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2026-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Respiratory viruses such as SARS-CoV-2 (the virus causing COVID-19) and Influenza A virus, have inarguably had an enormous impact on human health. Although vaccines have greatly limited COVID-19 and Influenza-related hospitalizations and deaths, these vir
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pre-clinical development of a novel class of broad-spectrum natural product antivirals
-
批准号:480228
-
项目类别:Operating Grants
-
资助金额:$57.4万
-
财政年份:2023
-
负责人:Jean François
-
依托单位:
Development and application of mass-spectrometry-based multiplexing assays for detecting Zika virus and uncovering novel anti-flaviviral strategies
-
批准号:366553
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2016
-
负责人:Jean François
-
依托单位:
Molecular and cellular studies of novel subtilase-directed secretory pathway serpins
-
批准号:178316
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2008
-
负责人:Jean François
-
依托单位:
海外基金